Xia Yiping's internal letter was alleged to have been copied from Weilai Li Bin. Xia Yiping, CEO of Jiyue, released an internal letter on the afternoon of 11th, acknowledging that the company was encountering difficulties and needed to adjust immediately. Some netizens pointed out that part of Xia Yiping's internal letter copied the internal letter of Weilai Li Bin in 2023. Xia Yiping's internal letter mentioned that the following four things must be done well in the new entrepreneurial period: 1. Adhere to the long-term investment in core technologies to maintain the leading edge; 2. Strengthen sales and service capacity building to cope with fierce market competition; 3. Merge departments and posts with duplicate functions and change inefficient internal workflow; 4. Reduce projects that cannot improve financial performance in the short term. In 2023, Li Bin's internal letter also mentioned: ensure long-term investment in core key technologies and maintain the leading edge of technology and products; Ensure that sales and service capabilities can cope with fierce market competition; Ensure that 9 core products of 3 brands are listed as scheduled; Organize efficiency improvement, merge redundant departments and posts, change inefficient internal workflow and division of labor, and cancel inefficient posts; Improve the efficiency of resources, postpone and reduce the project investment that can not improve the company's financial performance within 3 years. (Sina Technology)It is reported that NVIDIA has increased its recruitment in China, and it is expected to add 1,000 employees this year. According to people familiar with the matter, NVIDIA has increased its recruitment in China this year to enhance its research ability and focus on new autonomous driving technology. According to sources, the company is expected to have about 4,000 employees in China by the end of this year, compared with about 3,000 at the beginning of this year. As a key part of the expansion, NVIDIA added about 200 employees in Beijing to strengthen a research team engaged in autonomous driving research. One person familiar with the matter said that the company has also expanded its after-sales service and network software development team.Mei Ansen signed a strategic cooperation agreement with Shuguang Network Technology Co., Ltd. According to Mei Ansen, recently, Mei Ansen and Shuguang Network Technology Co., Ltd. held a strategic cooperation signing ceremony in Chongqing. The two sides reached a strategic cooperation to jointly build smart mine bases and comprehensive solutions. Shuguang Network Technology Co., Ltd. is a holding subsidiary of Zhongke Shuguang (603019).
The opposition party in South Korea said that Yin Xiyue was insane. On the morning of December 12, local time, South Korean President Yin Xiyue made another televised speech, refused to step down early, and denied that martial law was a crime of civil strife. After Yin Xiyue's speech, public opinion in South Korea immediately criticized him. South Korea's largest opposition party, the Common Democratic Party, said that Yin Xiyue was mentally ill and called on the South Korean National Assembly to pass the impeachment case. After Yin Xiyue's speech, Han Dongxun, the representative of the ruling party in South Korea, also said that Yin Xiyue's speech had no introspection and was rationalizing his behavior. Some commentators pointed out that Yin Xiyue may have expected that he could not prevent the National Assembly from passing the impeachment case and was trying to influence the final ruling of the Constitutional Court. I am afraid that the chaos in Korean politics will continue.Turkey imposes additional tax on Iranian flat glass imports.Indian Trade Secretary: India's export performance is very good. India's service trade will soon reach 50% of the total trade volume.
Iflytek and other robot technology companies have a registered capital of 30 million yuan. According to Tianyancha App, Anhui Lingdong General Robot Technology Co., Ltd. was recently established with Hu Guoping as the legal representative and a registered capital of 30 million yuan. Its business scope includes industrial robot manufacturing, industrial robot sales, intelligent robot research and development, electrical equipment sales, computer software and hardware and auxiliary equipment retail, information system integration services, intelligent robot sales, mechanical equipment leasing, etc. According to shareholder information, the company is jointly held by Anhui Xunfei Yunchuang Technology Co., Ltd., a subsidiary of Iflytek (002230), Anhui Yanzhi Technology Co., Ltd. and Anhui Lingji Wanwu Technology Partnership (Limited Partnership).It is reported that NVIDIA has increased its recruitment in China, and it is expected to add 1,000 employees this year. According to people familiar with the matter, NVIDIA has increased its recruitment in China this year to enhance its research ability and focus on new autonomous driving technology. According to sources, the company is expected to have about 4,000 employees in China by the end of this year, compared with about 3,000 at the beginning of this year. As a key part of the expansion, NVIDIA added about 200 employees in Beijing to strengthen a research team engaged in autonomous driving research. One person familiar with the matter said that the company has also expanded its after-sales service and network software development team.A former employee of Adebio was sentenced and involved in AstraZeneca employees' insurance fraud case. A former employee of the genetic testing company Aidebio, which worked closely with AstraZeneca, committed medical insurance fraud together with AstraZeneca sales staff during his tenure in the company. He was sentenced to three years' imprisonment and fined for fraud, and I pleaded guilty. A judgment obtained shows that Ma, a former employee of Aide Bio involved in the case, conspired with AstraZeneca employees to tamper with the genetic test report during his tenure. He began to accept public security investigation in September 2021 and was sentenced in August 2023. However, on December 9, 2024, the company replied that "there is no problem (cooperation with AstraZeneca), which has no impact on us and has nothing to do with us" and denied that any employees were involved. (financial magazine)
Strategy guide 12-14
Strategy guide 12-14
Strategy guide
12-14
Strategy guide
12-14
Strategy guide
Strategy guide 12-14